News 03. Apr. 2024 Nouscom receives additional funding for cancer vaccines Nouscom has received an investment totalling 7 million euros from the Italian venture capital firm Angelini Ventures. The Basel-based biotech com...
News 06. Dez. 2023 Philochem launches clinical trial for tumor imaging Philochem and Blue Earth Diagnostics have examined their first three patients as part of a Phase 1 clinical trial. The trial aims to develop a sm...
News 29. Nov. 2023 Metall Zug and Miele establish joint venture Metall Zug and Miele are establishing a joint venture. Metall Zug will integrate its business units specializing in the disinfection and steriliz...
Aktuell 02. Okt. 2023 10 innovative Health-Startups in der Greater Zurich Area In der Greater Zurich Area werden Innovationen entwickelt, produziert und auf den Markt gebracht, die das moderne Gesundheitswesen weltweit präge...
News 19. Okt. 2023 Researchers reverse prostate cancer therapy resistance Researchers at the Institute of Oncology Research (IOR) have discovered how to reverse prostate cancer therapy resistance. This advancement came ...
News 01. Sep 2023 App game teaches children about their rights The St.Gallen-based Eastern Switzerland University of Applied Sciences (OST), University of Teacher Education Lucerne and UNICEF Switzerland and ...
Actualités 12. Juli 2023 EBAMed lève EUR 14,35 millions pour promouvoir sa thérapie révolutionnaire d’ablation par radiation cardiaque La medtech genevoise EBAMed a levé EUR 14,35 millions en série A. Ce financement permettra d'accélérer le développement du système CardioKit, le ...
News 02. Okt. 2023 10 innovative healthcare startups in Greater Zurich to watch In the Greater Zurich Area, innovative healthcare innovations are being developed, produced, and launched to the market. We introduce 10 key play...
News 12. Juli 2023 EBAMed raises EUR 14.35 million to propel its groundbreaking cardiac radiation ablation therapy Geneva-based medtech EBAMed has successfully secured EUR 14.35 million in Series A funding. This financing will accelerate the development of the...
News 02. Juni 2023 Abiogen Pharma acquires majority stake in EffRx Abiogen, a pharmaceutical firm based in the Italian city of Pisa, has acquired a 97.09 percent stake in EffRx Pharmaceuticals. Since 2014, Abioge...
News 26. Apr. 2023 Life Sciences CC Association founded in Ticino The Life Sciences CC Association has officially been established. It will lead the competence center for life sciences research at the future Swi...
Evento di terzi Bridging Innovation: Unire i Tech Leader di Bergamo e Greater Zurich Area Bergamo Italy
Aktuell 16. Febr. 2022 Tessiner Onkologie erfährt weltweite Anerkennung Die Lymphomgruppe des Instituts für Onkologische Forschung und des Onkologischen Instituts der Südschweiz hat einen Leitfaden zur Erkennung von L...
Aktuell 14. Apr. 2022 Forschende entwerfen neuartigen Tumorhemmer Forschende des Paul Scherrer Instituts und des Istituto Italiano di Tecnologia haben am Computer ein Molekül entwickelt, das an Tumorzellen andoc...
News 16. Febr. 2022 Global recognition for Ticino oncology The lymphoma group of the Institute of Oncological Research and the Oncological Institute of Southern Switzerland has published a guide to detect...
News 04. Mai 2022 USI institute makes metastasis breakthrough Researchers from the Institute of Oncology Research at USI are celebrating a breakthrough: A team has developed a new therapy to prevent the form...
News 27. Juli 2022 US medical association to open regional office at UZH Zurich/Washington D.C. - The Faculty of Medicine at the University of Zurich is to take over the hosting and leadership of the European regional ...